Home Biosimilar Antibodies Protein Tyrosine Kinase VEGFR antibody Icrucumab (Anti-VEGFR1 / FLT1) For research use only.
Not for use in humans.

Icrucumab (Anti-VEGFR1 / FLT1)

Synonyms: iVR1

Icrucumab (Anti-VEGFR1 / FLT1) is a humanized Anti-VEGFR-1 IgG1 monoclonal antibody, with potential anti-tumor and anti-metastatic agent. It also act as a therapeutic anti-angiogenic agent in different pathological contexts.

Icrucumab (Anti-VEGFR1 / FLT1)

Purity & Quality Control

Batch: A230101 Purity: 99% Protein concentration: 7.44mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective VEGFR Inhibitors

Biological Activity

Description Icrucumab (Anti-VEGFR1 / FLT1) is a humanized Anti-VEGFR-1 IgG1 monoclonal antibody, with potential anti-tumor and anti-metastatic agent. It also act as a therapeutic anti-angiogenic agent in different pathological contexts.

Product Details

CAS No. 1024603-92-6
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Icrucumab (Anti-VEGFR1 / FLT1) | Icrucumab (Anti-VEGFR1 / FLT1) supplier | purchase Icrucumab (Anti-VEGFR1 / FLT1) | Icrucumab (Anti-VEGFR1 / FLT1) cost | Icrucumab (Anti-VEGFR1 / FLT1) manufacturer | order Icrucumab (Anti-VEGFR1 / FLT1) | Icrucumab (Anti-VEGFR1 / FLT1) distributor